You are here
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Regulation of autologous cell and tissue products and proposed consequential changes to the classification of biologicals
Closed on 6 October 2016
Closed on 3 March 2015
Proposed standards for human blood and blood components, human tissues and human cellular therapy products
Closed on 2 February 2011
Closed on 8 September 2010